Leica Biosystems Announces Expansion of Collaboration to Scale Precision Medicine and Develop AI-Powered Diagnostics
The Danaher company expands its collaboration with AstraZeneca and Daiichi Sankyo to develop an end-to-end system for TROP2 NMR in non-small cell lung cancer NEWCASTLE, United Kingdom, June 3, 2026 /PRNewswire/ -- Leica Biosystems, a Danaher company and a global leader in end-to-end...
The Danaher company expands its collaboration with AstraZeneca and Daiichi Sankyo to develop an end-to-end system for TROP2 NMR in non-small cell lung cancer NEWCASTLE, United Kingdom, June 3, 2026 /PRNewswire/ -- Leica Biosystems, a Danaher company and a global leader in end-to-end...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.